Followers | 237 |
Posts | 10817 |
Boards Moderated | 0 |
Alias Born | 07/17/2006 |
Wednesday, April 28, 2021 11:18:16 AM
I appreciate your interest in BNGO..but am concerned when you post daily charts and technical opinions that you might not be helping some us..
When you post daily support and resistance levels you provide a road map for anyone who is committed to taking the stock down..(ie counter trade most of us this site)..
I have no proof this is actually happening, but support levels ( for example $7 seems to be an important support and resistance level and it seems there is is little or no support due to concerted efforts of those involved with this issue..
":>)JL
Recent BNGO News
- Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/04/2024 05:44:35 PM
- Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance • GlobeNewswire Inc. • 03/19/2024 12:00:00 PM
- Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System • GlobeNewswire Inc. • 03/07/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:48:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:47:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:44:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:26:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:23:48 PM
- Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Bionano to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 01:16:10 PM
- Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024 • GlobeNewswire Inc. • 02/28/2024 01:01:00 PM
- Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis • GlobeNewswire Inc. • 02/22/2024 01:00:00 PM
- Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS • GlobeNewswire Inc. • 01/30/2024 01:00:00 PM
- Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing • GlobeNewswire Inc. • 01/24/2024 01:00:00 PM
- Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping • GlobeNewswire Inc. • 01/23/2024 01:00:00 PM
- Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications • GlobeNewswire Inc. • 01/19/2024 01:00:00 PM
- Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing • GlobeNewswire Inc. • 01/11/2024 09:01:00 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM